GermanyChemicals and materials2023 – ongoingMerck KGaA
myGPT employee generative AI platform
Merck reported more than 30,000 monthly users of myGPT and costs over 90% below commercial list-price alternatives
Problem
Merck needed to provide employees with secure access to generative AI across its businesses. Commercial enterprise subscriptions provided a cost benchmark for serving that workforce.
Approach
Merck provided myGPT for employee use and paired access with tailored training. Its October 2025 investor presentation reported more than 30,000 monthly active users. The company compared costs with the unnegotiated list prices of Microsoft 365 Copilot and ChatGPT Enterprise.
Results
Takeaway
The savings comparison used commercial list prices. It did not establish savings against negotiated contracts or measure employee time saved.
Categories
- Size
- Large enterprise
- Industry
- Chemicals and materials
- Business function
- Internal work and knowledge management
- Innovation type
- Process innovation
- AI technology
- Generative AI
- Adoption
- Off-the-shelf tool or platform
- Evidence
- Company's own claim
Sources
Source summaries
Merck described myGPT as its employee platform for secure, cost-efficient generative AI. It reported more than 30,000 monthly active users and savings exceeding 90% against specified commercial tools at unnegotiated list prices.
Full details are in the original sources.
